🔗 Permalink

Inventor profile of:

Mark Staples

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2016-02-04

Top Assignees for applications by Mark Staples

The entities that hold a legal rights for patent applications filed by inventor Staples Mark:

LA JOLLA PHARMACEUTICAL COMPANY 9 San Diego, CA United States
Biogen Idec MA Inc. 3 Cambridge, MA United States
BIOGEN IDEC MA INC. 3 Weston, MA United States
BIOGEN MA INC. 1 Cambridge, MA United States
La Jolla Pharmaceuticals Company 1 San Diego, CA United States
GlycoGenesys, Inc. 1 Boston, MA United States

Recent patent applications by Staples Mark

Mark Staples from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-02-04

US20160030467A1

Human necessities

Modified Pectins, Compositions and Methods Related Thereto

#2 | 2015-04-02

US20150093359A1

Human necessities

Stable liquid interferon beta formulations

#3 | 2015-03-26

US20150086642A1

Chemistry; metallurgy

Modified pectins, compositions and methods related thereto

#4 | 2014-08-14

US20140228317A1

Chemistry; metallurgy

Modified pectins, compositions and methods related thereto

#5 | 2013-11-14

US20130302281A1

Human necessities

Stable liquid interferon beta formulations

#6 | 2013-09-26

US20130251765A1

Chemistry; metallurgy

Modified pectins, compositions and methods related thereto

#7 | 2013-09-19

US20130243831A1

Chemistry; metallurgy

Modified pectins, compositions and methods related thereto

#8 | 2012-12-13

US20120315309A1

Human necessities

Modified pectins, compositions and methods related thereto

#9 | 2012-12-06

US20120309711A1

Human necessities

Modified pectins, compositions and methods related thereto

#10 | 2012-06-14

US20120149658A1

Human necessities

Modified pectins, compositions and methods related thereto

#11 | 2012-05-17

US20120123102A1

Human necessities

Modified pectins, compositions and methods related thereto

#12 | 2010-09-23

US20100239531A1

Human necessities

Methods of treating multiple sclerosis with stable liquid interferon-beta formulations

#13 | 2008-02-28

US20080050339A1

Human necessities

Stable liquid interferon formulations

#14 | 2008-02-28

US20080050338A1

Human necessities

Stable liquid interferon-beta formulations

#15 | 2008-02-21

US20080044381A1

Human necessities

Stable liquid interferon formulations

#16 | 2005-11-10

US20050250735A1

Human necessities

Modified pectins, compositions and methods related thereto

InventorID:

443776 ⎘